Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
Progression of cancer is often associated with interactions between cancer cells and extracellular matrix (ECM) surrounding them. Increasing evidence has suggested that accumulation of hyaluronan (HA), a major component of ECM, provides a favorable microenvironment for cancer progression. Pancreatic...
Saved in:
Main Authors: | Norihiro Sato (Author), Xiao-Bo Cheng (Author), Shiro Kohi (Author), Atsuhiro Koga (Author), Keiji Hirata (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
by: Alexander G. Raufi, et al.
Published: (2021) -
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Published: (2021) -
Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
by: Jinlu Liu, et al.
Published: (2023) -
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021) -
Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas
by: Marie-Lucie Racu, et al.
Published: (2024)